Oral ketamine adjunct for wound care in patients with burn injuries

Clicks: 24
ID: 327630
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #40 of 86 articles by views in journal of burn care & research : official publication of the american burn association

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Opioids and benzodiazepines provide the foundation for procedural sedation during wound care following burn injury. Ketamine has been used as an adjunct and may limit exposure to opioids. Few data are published describing the use of oral ketamine in this population. This study was performed to compare the effects of oral ketamine on opioid and benzodiazepine requirements during wound care following burn injury. This was a retrospective, single center cohort study (August 2022-2024). The electronic medical record was queried for adult (≥18 years) patients admitted to the burn intensive care unit who received oral ketamine as a premedication for wound care. The primary outcome was oral morphine equivalents (OMEs) before (pre) and after (post) initiation of oral ketamine. Only medications used during wound care were recorded. Descriptive statistics were utilized for analysis. A total of 52 patients were included. The median percent total body surface area (%TBSA) burned was 31 (IQR 20-48). The median ketamine dose received during wound care was 100 mg (IQR 100-125). All patients received IV fentanyl and 47 (90%) received IV midazolam. Patients received a median of 225 mg (IQR 150-300) vs 180 mg (IQR 120-240) (P=0.008) of OMEs in the pre- and post-groups, respectively. There was no difference in midazolam received (6 mg [IQR 4-8] vs 5 mg [IQR 3-8]; P = 0.21). Oral ketamine may be an effective adjunct to wound care following burn injury and may reduce exposure to opioids.
Reference Key
openalex_W7208750392 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Spencer Hayashi, Sierra Young, Erin Louie, Soman Sen
Journal journal of burn care & research : official publication of the american burn association
Year 2026
DOI
10.1093/jbcr/irag159
URL
https://doi.org/10.1093/jbcr/irag159
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.